每年專案
個人檔案
學歷
- 2001.08-2005.08 Ph.D. Department of Food Science and Biotechnology, National Chung Hsing University
- 2006.01-2010.01 Post-Doctoral Fellow, National Institute of Cancer Research (National Health Research Institutes)
經歷
- 2010.04- Assistant Professor, Graduate Institute of Clinical Medicine, Taipei Medical University
- 2014.02- Research Fellow and Executive Secretary, Taipei Medical University-Shuang Ho Hospital
獎項
- Chi-Tai Yeh received his Ph.D. in Food Science and Biotechnology from National Chung Hsing University. Dr. Yeh is currently the Research Fellow and Executive Secretary of Department of Research of Taipei Medical University-Shuang Ho Hospital. Dr. Yeh has contributed 2 book chapters, published 46 articles in the field of cancer & nutritional chemistry journal, and got 2 patents in the medical compound of cancer therapy. His major research interests include in cancer cell biology, cancer stem cell research, nutrigenomis and cancer chemoprevention with dietary phytochemicals.
研究興趣
- Cancer cell biology
- Cancer stem cell research
- Nutrigenomis and cancer chemoprevention with dietary phytochemicals
指紋
查看啟用 Chi-Tai Yeh 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
網路
國家層面的近期外部共同作業。通過按一下圓點深入探索詳細資料。
專案
- 2 已完成
研究成果
-
Correction to: Liu, h.w.; et al. enhanced hsa-mir-181d/p-stat3 and hsa-mir-181d/p-stat5a ratios mediate the anticancer effect of garcinol in stat3/5a-addicted glioblastoma. cancers 2019, 11, 1888
Liu, H. W., Lee, P. M., Bamodu, O. A., Su, Y. K., Fong, I. H., Yeh, C-T., Chien, M-H., Kan, I-H. & Lin, C-M., 十月 2020, 於: Cancers. 12, 10, p. 1-4 4 p., 2846.研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
開啟存取 -
Drug-eluting versus bare-metal stents for first myocardial infarction in patients with atrial fibrillation: A nationwide population-based cohort study
Chang, N. C., Hu, P., Chen, T. H., Mao, C. T., Hung, M. J., Yeh, C. T. & Hung, M. Y., 一月 1 2020, 於: PLoS ONE. 15, 1, e0227571.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Targeted PARP Inhibition Combined with FGFR1 Blockade is Synthetically Lethal to Malignant Cells in Patients with Pancreatic Cancer
Lai, S. W., Bamodu, O. A., Chen, J. H., Wu, A. T., Lee, W. H., Chao, T. Y. & Yeh, C. T., 四月 8 2020, 於: Cells. 9, 4研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Targeting BC200/miR218-5p Signaling Axis for Overcoming Temozolomide Resistance and Suppressing Glioma Stemness
Su, Y. K., Lin, J. W., Shih, J. W., Chuang, H. Y., Fong, I. H., Yeh, C-T. & Lin, C-M., 八月 8 2020, 於: Cells. 9, 8研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取1 引文 斯高帕斯（Scopus） -
Targeting the Epigenetic Non-Coding RNA MALAT1/Wnt Signaling Axis as a Therapeutic Approach to Suppress Stemness and Metastasis in Hepatocellular Carcinoma
Chang, H. L., Bamodu, O. A., Ong, J. R., Lee, W. H., Yeh, C. T. & Tsai, J. T., 四月 20 2020, 於: Cells. 9, 4研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取3 引文 斯高帕斯（Scopus）